Browsing: exerciseinspired

Boulder, Colorado-based Enveda has reported Phase I results for ENV-308, an oral small molecule designed to mimic Lac-Phe, a hormone the body produces during high-intensity exercise, positioning the drug as a potential maintenance therapy for patients who discontinue GLP-1 receptor agonists and subsequently regain weight